Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Laurent Leksell

Elekta AB (publ)

EPICA International develops, sells, and services advanced medical imaging platforms and robotic systems. They provide solutions for both human and animal imaging.

EPICA International

Varian provides software and machines for oncology, alongside patient data and care team solutions, focusing on Intelligent Cancer Care.

Metric
Company Name	Elekta AB (publ)	EPICA International	Varian
Symbol	EKTA-B
MSH ID	COM:ELEKTA	COM:EPICAINTERNATIONAL	COM:VARIAN
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Devices	Medical Technology
Country	SE	US	US
Stage		Debt Financing
Employee Count	4.58K
Website	elekta.com	epicainternational.com	varian.com
LinkedIn
Founders

Metric
Market Cap	2.23B
Enterprise Value
Monthly Web Traffic		88	235.65K
Web Traffic Growth		-0.94	0.90
Valuation
Raised Capital		13.50M

Metric
Revenue	1.66B
Revenue (LTM)
Revenue (NTM)
Gross Profit	526.27M
EBITDA	320.04M
Operating Income	216.11M
Net Income	119.12M
EPS	0.31
Diluted EPS	0.31
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.38
Operating Profit Margin	0.13
EBITDA Margin	0.19
Net Profit Margin	0.08
Return on Equity	0.14
Return on Assets	0.05
Return on Capital Employed	0.13

EKTA

COM:ELEKTA

Elekta

Last Close

63.10

25/11 09:40

Market Cap

24.39B

Beta: -

Volume Today

91.20K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	21.46
P/B Ratio	2.78
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.76
EV Multiple	8.89

Metric
Days Sales Outstanding	185.18
Days Payables Outstanding	56.31
Days Inventory Outstanding	113.85
Operating Cycle	280.33
Cash Conversion Cycle	232.23
Asset Turnover	0.59

Metric
Operating Cash Flow	225.16M
Free Cash Flow	74.75M
Cash Flow to Debt	0.52
Operating Cash Flow/Sales	0.17
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	254.26M
Accounts Receivable	28.64M
Inventory	298.18M
Goodwill
Debt to Capitalization	0.38
Debt to Assets	0.22
Current Ratio	1.07
Quick Ratio	0.82

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.08
SG&A to Revenue	0.08